RxDoctor Payments Data

Timothy McGraw, MD

Dermatology · Birmingham, ALNPI 1265433494

Payments from drug & device makers

$2,064in general payments, 2019–2025

Across 103 payments — averaging $20.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • UCB, Inc.$140
  • Novartis$131
  • Kerecis Limited$111
  • Amgen$99
  • LEO Pharma Inc.$78
  • plus $424 from 14 others

What the payments were for

  • Food & beverage$2,064100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie61$1,082
UCB, Inc.4$140
Novartis6$131
Kerecis Limited1$111
Amgen6$99
LEO Pharma Inc.4$78
E.r. Squibb & Sons, L.L.C.3$63
Sanofi2$58
Johnson & Johnson3$57
Arcutis Biotherapeutics, Inc.2$44
EPI Health, LLC2$35
Galderma Laboratories, L.p.1$30
Regeneron Healthcare Solutions, Inc.1$25
DUSA Pharmaceuticals, Inc.1$20
Nabriva Therapeutics, PLC1$19
Pfizer1$18
Bristol Myers Squibb1$16
Strata Skin Sciences, Inc.1$16
Lilly USA, LLC1$12
Prugen, Inc. Pharmaceuticals1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,064 in reported general payments places this provider in the 35th percentile of 168 dermatology providers in Alabama.

See all dermatology providers in Alabama

Medicare billing

Part B allowed, 2024
$121,245
Medicare patients
385
Services billed
1,994

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate131$5,560
Ketoconazole199$3,311
Doxycycline Hyclate97$2,498
Triamcinolone Acetonide211$2,249
Betamethasone Dipropionate31$1,782
Metronidazole17$1,364
Fluorouracil17$1,252
Clindamycin Phosphate14$680
Hydroxychloroquine Sulfate11$634
CiclopiroxCiclopirox Olamine41$617
Terbinafine Hcl48$509
Mupirocin59$472
Nystatin37$460
Hydrocortisone44$337
ValacyclovirValacyclovir Hcl16$244

Paid to pharmacies, not to this prescriber.

Other dermatology in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →